
An International Publisher for Academic and Scientific Journals
Author Login
Scholars Journal of Applied Medical Sciences | Volume-5 | Issue-02
A correlative study of Epicardial fat thickness with other cardiovascular risk factors in patients with prediabetes
Ritu Karoli, Nikhil Gupta, Jalees Fatima, Zeba Siddiqi, Vaibhav Shukla, Shishir Varshney
Published: Feb. 28, 2017 |
209
158
DOI: 10.36347/sjams.2017.v05i02.061
Pages: 612-616
Downloads
Abstract
Prediabetes is a condition between a normal glucose tolerance and diabetes mellitus. It includes impaired
glucose tolerance (IGT), impaired fasting glucose (IFG), or both. Prediabetes is related with undesirable cardiovascular
outcomes. Epicardial fat thickness (EFT) has been correlated with cardiovascular risk factors. We herein aimed to assess
EFT in prediabetic patients. We evaluated100 patients with prediabetes and 100 age- and gender-matched healthy
subjects. Demographic and anthropometric characteristics [age, sex, height, weight, body mass index (BMI), and waist
circumference (WC)] and laboratory findings [fasting plasma glucose (FPG), postprandial plasma glucose (PPG),
hemoglobin A1c (HbA1c), low density lipoprotein (LDL), high density lipoprotein (HDL), and triglycerides (TG)] were
assessed. Transthoracic echocardiography was used to evaluate EFT. All the study subjects were also subjected for
assessment of hepatic steatosis. There were no significant differences between the case and control groups in terms of
age, gender, and BMI., Waist circumference, systolic and diastolic blood pressure were found to be significantly higher
in the case group than control group (p<0.05). When compared with the control group, the mean EFT was significantly
higher in all prediabetic subgroups (IGT or IFG, p<0.001) than controls. The presence of hepatic steatosis had significant
positive correlation with EFT. We concluded that EFT levels to be increased in all prediabetic patients regardless of FPG
and HbA1c. Furthermore, EFT significantly correlated with the patients' WC and hepatic steatosis.